Otenabant Completed Phase 1 Trials for Non-Alcoholic Steatohepatitis (NASH) Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT00706537Phase 1 Pharmacokinetic Study Of CP-945598 In Patients With NASH